68
Participants
Start Date
May 18, 2023
Primary Completion Date
March 29, 2024
Study Completion Date
July 30, 2026
Dexamethasone
Dexamethasone will be administered orally.
Montelukast
Montelukast will be administered orally.
Methotrexate
Methotrexate will be administered subcutaneously.
Amivantamab
Amivantamab will be administered intravenously.
Lazertinib
Lazertinib tablets will be administered orally.
Taipei Medical University, Taipei
Taipei Veterans General Hospital, Taipei
Changhua Christian Hospital, Changhua
Hosp. Univ. Quiron Dexeus, Barcelona
Hosp. San Pedro de Alcantara, Cáceres
National Taiwan University Hospital, Taipei
National Cancer Center, Gyeonggi-do
Hosp. de Jerez de La Frontera, Jerez de la Frontera
Seoul National University Bundang Hospital, Seongnam-si
Hosp. Clinico Univ. de Santiago, Santiago de Compostela
Gachon University Gil Medical Center, Incheon
Virginia Cancer Specialists, Fairfax
Hosp. Gral. Univ. Gregorio Maranon, Madrid
Hosp. Univ. 12 de Octubre, Madrid
Chungbuk National University Hospital, Cheongju-si
Hosp Virgen de La Victoria, Málaga
CHU de Brest - Hopital de la Cavale Blanche, Brest
Taichung Veterans General Hospital, Taichung
Inst. Valenciano de Oncologia, Valencia
Hosp. Gral. Univ. Valencia, Valencia
Hosp. Clinico Univ. Lozano Blesa, Zaragoza
Chonnam National University Hwasun Hospital, Jeollanam-do
Nouvel Hopital Civil - CHU Strasbourg, Strasbourg
Centre Leon Berard, Lyon
Chi-Mei Medical Center, Liouying, Tainan City
Hopital Cochin, Paris
Hopital Europeen Georges-Pompidou, Paris
CHU Rouen Hopital Charles Nicolle, Rouen
Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung City
Compassionate Cancer Care, Fountain Valley
UW Medicine Valley Medical Center, Renton
Asan Medical Center, Seoul
Hosp. de La Santa Creu I Sant Pau, Barcelona
Hosp Univ Vall D Hebron, Barcelona
Inst. Cat. Doncologia-H Duran I Reynals, L'Hospitalet de Llobregat
Hosp. Univ. Son Espases, Palma de Mallorca
Janssen Research & Development, LLC
INDUSTRY